Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC

IntroductionTo determine the safety and efficacy of neoadjuvant toripalimab combined with chemotherapy in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).Patients and methodsThis single-arm investigator-initiated trial was conducted at a tertiary cancer hospital in China. The untre...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Zhaoyang Wang, Sheng Yang, Dangui Yan, Ye Zhang, Xiwei Zhang, Fa Zhang, Xiaohui Zhao, Zongmin Zhang, Shaoyan Liu, Lin Gui, Changming An
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	head and neck squamous cell carcinoma (HNSCC) immunotherapy neoadjuvant therapy toripalimab safety and efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1571776/full